North America is Dominating the Global Nucleic Acid Isolation and Purification Market with Maximum Revenue

 

Nucleic acid isolation and purification is the preliminary step in the field of molecular biology research accompanied by recombinant techniques. The nucleic acid isolation process majorly includes enzymatic digestion and mechanical and chemical disruption. On the other hand, purification consists of a combination of precipitation, chromatography, centrifugation, electrophoresis, and separation.

The process of nucleic acid isolation aids sample processing by reducing the time, significantly minimizes nucleic acid loss, and enhances experimental process efficiency and effectiveness. The obtained purified product is further used in recombinant technology methods, thereby making it suitable for targeted purposes in the field of omics research. The advantages offered by nucleic acid isolation and purification significantly aid scientists and researchers to obtain high-quality starting material for conducting downstream applications, thereby generating accurate results.

According to the market intelligence published by BIS Research, the nucleic acid isolation and purification market is projected to grow at a significant CAGR of 5.98% during the forecast period, 2020-2029. The market was estimated at $2273.9 million in 2018.

The end users in Nucleic acid isolation and purification market are expected to witness a wide variety of applications, and automation has further facilitated applications, such as genomic/plasmid DNA, cell-free DNA (cfDNA), viral RNA, and cell-free RNA (cfRNA). Automation in nucleic acid isolation and purification offers high throughput, further reducing sample processing time.

Factors such as the increasing prevalence of genetic diseases, rising research in the field of molecular biology, growing awareness and acceptance of precision medicine worldwide, and rising research funding from government and private institutions, are further supporting the adoption of automated nucleic acid isolation and purification products.

As of 2019, North America was the dominating region in terms of revenue generated in the global market. The presence of full-fledged operational units of conglomerate companies contributing to this market significantly provided help in the establishment of several emerging players, further contributing significantly to the technological innovations in the nucleic acid isolation and purification market.

Presently, in the Europe region, Germany, the U.K., and France are the dominating countries in the Europe nucleic acid isolation and purification market. Factors such as growing demand for pharmaceuticals, increasing genomic research by government and private institutions, and significant adoption of technologically advanced nucleic acid isolation products, are expected to support the market growth in the forthcoming years.

The global nucleic acid isolation and purification market have a long way to go with large, as well as small players, operating at the global and regional levels. Some of the prominent players in this market are Promega Corporation, F. Hoffmann-La Roche AG, Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., and Merck KGaA.